Potentiation of tau aggregation by cdk5 and GSK3β

Journal of Alzheimer's Disease

Volumn 26, Issue 2, 2011, Pages 355-364

  Lee, Sangmook ^a   Hall, Garth F ^a   Shea, Thomas B ^a  

^a University of Massachusetts Lowell   (United States)

Author keywords

Aggregation; caspase; cdk5; cleavage; GSK3 ; lithium; okadaic acid; phosphorylation; PP2A; roscovitine; tau

Indexed keywords

CYCLIN DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM; MUTANT PROTEIN; OKADAIC ACID; ROSCOVITINE; TAU PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL AGGREGATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 80052795886     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-102016     Document Type: Article

References (43)

1. Binder LI, Frankfurter A, Rebhun LI (1985) The distribution of tau in the mammalian central nervous system. J Cell Biol 101, 1371-1378. (Pubitemid 16203754)
2. Binder LI, Guillozet-Bongaarts AL, Garcia-Sierra F, Berry RW (2005) Tau, tangles, and Alzheimer's disease. Biochim Biophys Acta 1739, 216-223. (Pubitemid 40018540)
3. Kanai Y, Hirokawa N (1995) Sorting mechanisms of tau and MAP2 in neurons: suppressed axonal transit of MAP2 and locally regulated microtubule binding. Neuron 14, 421-432.
4. Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegener-ative tauopathies. Annu Rev Neurosci 24, 1121-1159.
5. Riederer BM, Innocenti GM (1991) Differential distribution of tau proteins in developing cat cerebral cortex and corpus callosum. Eur J Neurosci 3, 1134-1145.
6. Swaab DF, Dubelaar EJ, Hofman MA, Scherder EJ, van Someren EJ, Verwer RW (2002) Brain aging and Alzheimer's disease; use it or lose it. Prog Brain Res 138, 343-373. (Pubitemid 35460922)
7. Tashiro K, Hasegawa M, Ihara Y, Iwatsubo T (1997) Somato-dendritic localization of phosphorylated tau in neonatal and adult rat cerebral cortex. Neuroreport 8, 2797-2801. (Pubitemid 27373532)
8. Avila J, Lucas JJ, Perez M, Hernandez F (2004) Role of tau protein in both physiological and pathological conditions. Physiol Rev 84, 361-384. (Pubitemid 38365487)
9. Pevalova M, Filipcik P, Novak M, Avila J, Iqbal K (2006) Post-translational modifications of tau protein. Bratisl Lek Listy 107, 346-353.
10. Ko LW, DeTure M, Sahara N, Chihab R, Vega IE, Yen SH (2005) Recent advances in experimental modeling of the assembly of tau filaments. Biochim Biophys Acta 1739, 125-139. (Pubitemid 40018534)
11. Yao TM, Tomoo K, Ishida T, Hasegawa H, Sasaki M, Taniguchi T (2003) Aggregation analysis of the microtubule binding domain in tau protein by spectroscopic methods. J Biochem 134, 91-99. (Pubitemid 37071184)
12. Geschwind DH (2003) Tau phosphorylation, tangles, and neu-rodegeneration: the chicken or the egg? Neuron 40, 457-460.
13. Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH (1992) Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett 147, 58-62.
14. Vulliet R, Halloran SM, Braun RK, Smith AJ, Lee G (1992) Proline-directed phosphorylation of human tau protein. J Biol Chem 267, 22570-22574.
15. Gong CX, Grundke-Iqbal I, Damuni Z, Iqbal K (1994) Dephosphorylation of microtubule-associated protein tau by protein phosphatase-1 and-2c and its implication in Alzheimer disease. FEBS Lett 341, 94-98.
16. Gong CX, Grundke-Iqbal I, Iqbal K (1994) Dephosphoryla-tion of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A. Neuroscience 61, 765-772. (Pubitemid 24291919)
17. Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K (1994) Alzheimer's disease abnormally phosphorylated tau is dephosphorylated by protein phosphatase-2B (calcineurin). J Neurochem 62, 803-806. (Pubitemid 24041353)
18. Goedert M, Jakes R, Qi Z, Wang JH, Cohen P (1995) Protein phosphatase 2A is the major enzyme in brain that dephospho-rylates tau protein phosphorylated by proline-directed protein kinases or cyclic amp-dependent protein kinase. J Neurochem 65, 2804-2807.
19. Sontag E, Nunbhakdi-Craig V, Lee G, Brandt R, Kamibayashi C, Kuret J, White CL, 3rd, Mumby MC, Bloom GS (1999) Molecular interactions among protein phosphatase 2a, tau, and microtubules. Implications for the regulation of tau phos-phorylation and the development of tauopathies. J Biol Chem 274, 25490-25498.
20. Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K (1993) Phos-phoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 61, 921-927. (Pubitemid 23241228)
21. Kins S, Crameri A, Evans DR, Hemmings BA, Nitsch RM, Gotz J (2001) Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentaliza-tion of tau in transgenic mice. J Biol Chem 276, 38193-38200.
22. Iliev AI, Ganesan S, Bunt G, Wouters FS (2006) Removal of pattern-breaking sequences in microtubule binding repeats produces instantaneous tau aggregation and toxicity. J Biol Chem 281, 37195-37204. (Pubitemid 46042189)
23. Ferrari A, Hoerndli F, Baechi T, Nitsch RM, Gotz J (2003) beta-Amyloid induces paired helical filament-like tau filaments in tissue culture. J Biol Chem 278, 40162-40168. (Pubitemid 37248584)
24. Vogelsberg-Ragaglia V, Bruce J, Richter-Landsberg C, Zhang B, Hong M, Trojanowski JQ, Lee VM (2000) Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Mol Biol Cell 11, 4093-4104.
25. Jung C, Yabe J, Wang FS, Shea TB (1998) Neurofilament subunits can undergo axonal transport without incorporation into Triton-insoluble structures. Cell Motil Cytoskeleton 40, 44-58. (Pubitemid 28225541)
26. Yabe JT, Chan WK, Chylinski TM, Lee S, Pimenta AF, Shea TB (2001) The predominant form in which neurofilament subunits undergo axonal transport varies during axonal initiation, elongation, and maturation. Cell Motil Cytoskeleton 48, 61-83. (Pubitemid 32037407)
27. Cho JH, Johnson GV (2004) Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ. J Biol Chem 279, 54716-54723. (Pubitemid 40053216)
28. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, Cryns VL (2003) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci USA 100, 10032-10037. (Pubitemid 37087063)
29. Cruz JC, Tseng HC, Goldman JA, Shih H, Tsai LH (2003) Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40, 471-483. (Pubitemid 37494698)
30. Jackson GR, Wiedau-Pazos M, Sang TK, Wagle N, Brown CA, Massachi S, Geschwind DH (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34, 509-519. (Pubitemid 34628749)
31. Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J (2001) Decreased nuclear beta-catenin, tau hyperphos-phorylation and neurodegeneration in GSK-3beta conditional transgenic mice. Embo J 20, 27-39. (Pubitemid 32099099)
32. Noble W, Olm V, Takata K, Casey E, Mary O, Meyerson J, Gaynor K, LaFrancois J, Wang L, Kondo T, Davies P, Burns M, Veeranna, Nixon R, Dickson D, Matsuoka Y, Ahlijanian M, Lau LF, Duff K (2003) Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38, 555-565. (Pubitemid 36645031)
33. DeFuria J, Shea TB (2007) Arsenic inhibits neurofilament transport and induces perikaryal accumulation of phosphory-lated neurofilaments: roles of JNK and GSK-3beta. Brain Res 1181, 74-82. (Pubitemid 350050903)
34. Moran CM, Donnelly M, Ortiz D, Pant HC, Mandelkow EM, Shea TB (2005) Cdk5 inhibits anterograde axonal transport of neurofilaments but not that of tau by inhibition of mitogen-activated protein kinase activity. Brain Res Mol Brain Res 134, 338-344.
35. Johnson GV (2006) Tau phosphorylation and proteolysis: insights and perspectives. J Alzheimers Dis 9, 243-250. (Pubitemid 44253316)
36. Litersky JM, Johnson GV (1992) Phosphorylation by CAMP-dependent protein kinase inhibits the degradation of tau by calpain. J Biol Chem 267, 1563-1568.
37. Sahara N, Murayama M, Lee B, Park JM, Lagalwar S, Binder LI, Takashima A (2008) Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphory-lation by GSK-3beta is required for tau aggregation. Eur J Neurosci 27, 2897-2906. (Pubitemid 351832217)
38. Sengupta A, Kabat J, Novak M, Wu Q, Grundke-Iqbal I, Iqbal K (1998) Phosphorylationoftauatboth Thr 231 and Ser 262 is required for maximal inhibition of its bindingtomicrotubules. Arch Biochem Biophys 357, 299-309. (Pubitemid 28419212)
39. Palmer H, Basak A (2009) Effect of phosphorylation on tau aggregation using model peptides and circular dichroism studies. Adv Exp Med Biol 611, 259-261.
40. Brion JP, Octave JN, Couck AM (1994) Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons. Neuroscience 63, 895-909. (Pubitemid 24360241)
41. Brion JP, Smith C, Couck AM, Gallo JM, Anderton BH (1993) Developmental changes in tau phosphorylation: fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease. J Neurochem 61, 2071-2080. (Pubitemid 23354063)
42. Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci USA 98, 6923-6928. (Pubitemid 32538318)
43. Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A. (2002) Tau is essential to beta-amyloid-induced neurotoxic-ity. Proc Natl Acad Sci USA 99, 6364-6369.